Evidence map›Paper›PMID 41184278›Full record

ArticleNature communications2025

Complex de novo structural variants are an underestimated cause of rare disorders.

Hyunchul Jung, Tsun-Po Yang, Susan Walker, Petr Danecek, O Isaac Garcia-Salinas, Matthew D C Neville, Joseph Christopher, Isidro Cortés-Ciriano, Helen Firth, Aylwyn Scally and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Hyunchul JungWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. hj6@sanger.ac.uk.ORCID http://orcid.org/0000-0003-0450-2190
Tsun-Po YangWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Susan WalkerGenomics England, London, UK.ORCID http://orcid.org/0000-0002-5016-6426
Petr DanecekWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
O Isaac Garcia-SalinasWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0003-2550-569X
Matthew D C NevilleWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0001-5816-7936
Joseph ChristopherWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Isidro Cortés-CirianoWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2036-494X
Helen FirthWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Aylwyn ScallyDepartment of Genetics, University of Cambridge, Downing Street, Cambridge, UK.ORCID http://orcid.org/0000-0002-0807-1167
Matthew HurlesWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2333-7015
Peter CampbellWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-3921-0510
Raheleh RahbariWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. rr11@sanger.ac.uk.ORCID http://orcid.org/0000-0002-1839-7785

Funding

Cancer Research UK (CRUK) Cancer Research UKRCUK | Medical Research Council (MRC) MR/W025353/1Wellcome Trust
6 · The paper itself

Abstract

Complex de novo structural variants (dnSVs) are crucial genetic factors in rare disorders, yet their prevalence and characteristics in rare disorders remain poorly understood. Here, we conduct a comprehensive analysis of whole-genome sequencing data of 12,568 families, including 13,698 offspring with rare diseases, obtained as part of the UK 100,000 Genomes Project. We identify 1,870 dnSVs, constituting the largest dnSV dataset reported to date. Complex dnSVs (n = 158; 8.4%) emerge as the third most common type of SV, following simple deletions and duplications. We classify 65% of these complex dnSVs into 11 subtypes. Among probands with dnSVs (n = 1,696), 9% exhibit exon-disrupting pathogenic dnSVs associated with the probands' phenotype. Notably, 12% of exon-disrupting pathogenic dnSVs and 22% of de novo deletions or duplications previously identified by array-based or whole-exome sequencing methods are found to be complex dnSVs. We also find distinct genomic properties of de novo deletions depending on the parent of origin. This study highlights the importance of complex dnSVs in the cause of rare disorders and demonstrates the necessity of specific genomic analysis to avoid overlooking these variants.

Indexed as

Genomic Structural VariationRare DiseasesExome SequencingExonsFemaleGene DuplicationGenetic Predisposition to DiseaseGenome, HumanHumansMalePhenotypeUnited KingdomWhole Genome Sequencing

Identifiers

PMID41184278
PMCPMC12583596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.